1. Home
  2. COEP vs FCUV Comparison

COEP vs FCUV Comparison

Compare COEP & FCUV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • FCUV
  • Stock Information
  • Founded
  • COEP 2017
  • FCUV 2012
  • Country
  • COEP United States
  • FCUV United States
  • Employees
  • COEP N/A
  • FCUV N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • FCUV Industrial Machinery/Components
  • Sector
  • COEP Health Care
  • FCUV Industrials
  • Exchange
  • COEP Nasdaq
  • FCUV Nasdaq
  • Market Cap
  • COEP 32.0M
  • FCUV 27.6M
  • IPO Year
  • COEP N/A
  • FCUV N/A
  • Fundamental
  • Price
  • COEP $8.03
  • FCUV $4.14
  • Analyst Decision
  • COEP
  • FCUV
  • Analyst Count
  • COEP 0
  • FCUV 0
  • Target Price
  • COEP N/A
  • FCUV N/A
  • AVG Volume (30 Days)
  • COEP 25.9K
  • FCUV 15.8K
  • Earning Date
  • COEP 08-15-2025
  • FCUV 08-13-2025
  • Dividend Yield
  • COEP N/A
  • FCUV N/A
  • EPS Growth
  • COEP N/A
  • FCUV N/A
  • EPS
  • COEP N/A
  • FCUV N/A
  • Revenue
  • COEP $62,874.00
  • FCUV $408,887.00
  • Revenue This Year
  • COEP N/A
  • FCUV N/A
  • Revenue Next Year
  • COEP N/A
  • FCUV N/A
  • P/E Ratio
  • COEP N/A
  • FCUV N/A
  • Revenue Growth
  • COEP N/A
  • FCUV 6.49
  • 52 Week Low
  • COEP $2.31
  • FCUV $1.50
  • 52 Week High
  • COEP $13.70
  • FCUV $10.90
  • Technical
  • Relative Strength Index (RSI)
  • COEP 43.91
  • FCUV 55.68
  • Support Level
  • COEP $6.80
  • FCUV $3.60
  • Resistance Level
  • COEP $8.86
  • FCUV $3.99
  • Average True Range (ATR)
  • COEP 0.62
  • FCUV 0.24
  • MACD
  • COEP -0.05
  • FCUV 0.06
  • Stochastic Oscillator
  • COEP 45.88
  • FCUV 77.50

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About FCUV Focus Universal Inc.

Focus Universal Inc offers smart devices, IoT products, and patented products and technologies for 5G telecommunications and network security. It is focused on commercializing its universal smart technology and financial reporting software. Its product line includes various digital, analog, and quantum light meters and filtration products, the Ubiquitor universal smart device, SEC Financial Reporting Software, and other smart devices and sensors. The company's reportable segments are Corporate and IoT, which derives maximum revenue, and Perfecular and Lusher. The Corporate and IoT segment includes its LED and IoT installation and management business (under Smart AVX), specializing in LED and display systems, home theaters, lighting control, automation, and integration.

Share on Social Networks: